Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Lambert

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Human Virology|March 22, 2002
Assessment of a rapid HIV test strategy during labor: a pilot study from Rio de Janeiro, BrazilS A Nogueira, J S Lambert, A L Albuquerque, et al.
The Journal of Antimicrobial Chemotherapy|May 6, 2026
Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancyL van der Wekken-Pas, C Hidalgo-Tenorio, J K Rockstroh, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|August 9, 2001
Successful prevention of hiv transmission from mother to infant in Brazil using a multidisciplinary team approachS A Nogueira, T Abreu, R Oliveira, et al.
The New England Journal of Medicine|August 5, 1999
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 TeamL M Mofenson, J S Lambert, E R Stiehm, et al.
HIV Medicine|August 24, 2010
Therapeutic drug monitoring of lopinavir/ritonavir in pregnancyJ S Lambert, L J Else, V Jackson, et al.
The Journal of Infectious Diseases|September 9, 1999
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant womenP F Wright, J S Lambert, G J Gorse, et al.
The Journal of Infectious Diseases|February 1, 1997
Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study GroupJ S Lambert, L M Mofenson, C V Fletcher, et al.
Sexually Transmitted Infections|November 7, 2008
Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conceptionE S Machado, C B Hofer, T T Costa, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218)J S Lambert, J McNamara, S L Katz, et al.
AIDS (London, England)|August 10, 2000
Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 TeamJ S Lambert, D H Watts, L Mofenson, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Human Virology|March 22, 2002
Assessment of a rapid HIV test strategy during labor: a pilot study from Rio de Janeiro, BrazilS A Nogueira, J S Lambert, A L Albuquerque, et al.
The Journal of Antimicrobial Chemotherapy|May 6, 2026
Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancyL van der Wekken-Pas, C Hidalgo-Tenorio, J K Rockstroh, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|August 9, 2001
Successful prevention of hiv transmission from mother to infant in Brazil using a multidisciplinary team approachS A Nogueira, T Abreu, R Oliveira, et al.
The New England Journal of Medicine|August 5, 1999
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 TeamL M Mofenson, J S Lambert, E R Stiehm, et al.
HIV Medicine|August 24, 2010
Therapeutic drug monitoring of lopinavir/ritonavir in pregnancyJ S Lambert, L J Else, V Jackson, et al.
The Journal of Infectious Diseases|September 9, 1999
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant womenP F Wright, J S Lambert, G J Gorse, et al.
The Journal of Infectious Diseases|February 1, 1997
Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study GroupJ S Lambert, L M Mofenson, C V Fletcher, et al.
Sexually Transmitted Infections|November 7, 2008
Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conceptionE S Machado, C B Hofer, T T Costa, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218)J S Lambert, J McNamara, S L Katz, et al.
AIDS (London, England)|August 10, 2000
Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 TeamJ S Lambert, D H Watts, L Mofenson, et al.
Pageof 7